Ginkgo Biloba 60 mg

Ginkgo Biloba 60 mg

NOW4.8 (3,857 ratings)
Format:Capsule Quantity: 240 Capsule(s) · 240 servings
Goals
$6.99 $0.02 per serving

Product analysis

62 out of 100

Ginkgo Biloba 60 mg offers a simple ginkgo supplement with a possible but uncertain connection to attention. Findings for everyday memory and focus are mixed and depend on the extract used.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

The main ginkgo compounds are identified, helping describe the extract. Its preparation quality remains uncertain because those details do not establish equivalence to a specific studied extract.

Ingredient Transparency100

Amounts, named components and their composition are disclosed, making the extract easier to compare. Separate ginkgo declarations still require care because they do not establish a single interchangeable preparation.

Value For Money40

Value for the ginkgo contribution cannot be established confidently. Differing amount declarations also limit a straightforward quantity-to-cost comparison.

Customer Satisfaction89

Customer feedback is strongly positive. Thousands of ratings provide a broad picture of buyer satisfaction, without establishing cognitive benefits.

Product Focus58

A single herb keeps the formula simple and focused. Its proposed cognitive and vision uses have limited or mixed support, so everyday benefits remain uncertain.

Format
Capsule
Container
240 Capsule(s)
Per serving
$0.02
Customer rating
4.8 · 3,857 ratings
Report analysis

Goals

Brain Health
Impact
Moderate effect
A Ingredient FitD- PathwaysC- EvidenceA+ Formulation Logic

The supplied facts list 260 mg ginkgo, with the main connection to brain energy processes. Evidence for routine cognitive benefit is limited, and findings in clinical populations do not guarantee an improvement for healthy users.

How this product is rated for Brain Health

Ingredient fit94

The relevant ingredients are the clear focus of the formula. The counted ingredient amounts reach the saved comparison benchmarks.
Goal fit
The relevant ingredients are the clear focus of the formula.
Dose adequacy
The counted ingredient amounts reach the saved comparison benchmarks.

Pathways43

The clearest connection is to brain energy processes, with substantial coverage in the saved findings. One reviewed mechanism has sufficient support; the overall range remains narrow.
Depth
The clearest connection is to brain energy processes, with substantial coverage in the saved findings.
Breadth
One reviewed mechanism has sufficient support; the overall range remains narrow.

Evidence58

Ginkgo provides the strongest evidence among ingredients counted at a meaningful amount. The practical benefit remains dependent on context. The counted ingredients at meaningful amounts match preparations accepted in the saved assessment.
Evidence strength
Ginkgo provides the strongest evidence among ingredients counted at a meaningful amount. The practical benefit remains dependent on context.
Studied preparation
The counted ingredients at meaningful amounts match preparations accepted in the saved assessment.

Formulation logic100

The relevant ingredients can contribute independently or have their required partner. No ingredient conflicts were identified in the saved assessment.
Partner coverage
The relevant ingredients can contribute independently or have their required partner.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
1 of 1 relevant ingredients reach the saved meaningful-amount threshold.
Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Impact
Moderate effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic

Ginkgo has preliminary relevance to acute attention-speed tasks and cerebral blood-flow mechanisms. The separate ginkgo declarations are not identified as the studied preparation, and their combined mass does not establish preparation equivalence or long-term cognitive benefit.

How this product is rated for Cognitive Support

Ingredient fit94

Ginkgo gives a focused composition and matches the saved exposure reference.
Goal fit
Ginkgo gives a focused composition and matches the saved exposure reference..
Dose adequacy
The ginkgo declarations meet the full saved exposure reference.

Pathways40

Cerebral blood flow is the main area represented in the saved findings. One core area reaches meaningful coverage, giving narrow breadth.
Depth
Cerebral blood flow is the main area represented in the saved findings.
Breadth
One core area reaches meaningful coverage, giving narrow breadth.

Evidence25

Ginkgo supplies preliminary acute-task evidence with limited confidence for unidentified material. The relevant material is not identified as a studied cognitive preparation.
Evidence strength
Ginkgo supplies preliminary acute-task evidence with limited confidence for unidentified material.
Studied preparation
The relevant material is not identified as a studied cognitive preparation.

Formulation logic100

The relevant ingredients can contribute without an additional required partner. All ingredients counted in the saved effective-exposure finding reach its minimum level.
Partner coverage
The saved assessment finds no missing required partner for the relevant ingredients.
Conflicts
No listed cognitive-performance conflict was found in the supplied assessment.
Effective doses
All ingredients counted in the saved effective-exposure finding reach its minimum level.
Study evidence
Ginkgo Supportive 87 studies
Impact
Moderate effect
A Ingredient FitC PathwaysC EvidenceA+ Formulation Logic

Whether ginkgo helps everyday vision is unclear. Its connection to the eyes concerns blood flow, but effects depend on the extract and the circumstances in which it's used. The declared amount alone doesn't show that it will improve how clearly you see or your ability to distinguish contrast.

How this product is rated for Eye Health

Ingredient fit94

Ginkgo is the sole ingredient connected with this goal, with uncertainty about everyday visual benefit.
Goal fit
Ginkgo is the only relevant active here; its practical usefulness for routine vision remains uncertain.
Dose adequacy
The serving supplies 260 mg ginkgo; the comparison anchors are 120–240 mg, without guaranteeing an everyday vision benefit.

Pathways60

The connection concerns blood flow in the eyes; an improvement in everyday vision remains uncertain.
Depth
The connection concerns blood flow in the eyes; an improvement in everyday vision remains uncertain.
Breadth
The connection is concentrated on ocular blood flow.

Evidence64

Ginkgo effects are specific to extracts and particular eye conditions; a general everyday vision benefit remains uncertain.
Evidence strength
Ginkgo effects are specific to extracts and particular eye conditions; a general everyday vision benefit remains uncertain.
Studied preparation
The ginkgo form is recognized, but extract-specific effects cannot be generalized to routine vision improvement.

Formulation logic100

No particular ingredient conflict is identified, and no missing partner is identified for the ingredients involved.
Partner coverage
No missing partner is identified for the relevant ingredients.
Conflicts
No particular conflict between the ingredients is identified.
Effective doses
The relevant declared amounts span their comparison ranges; these ranges do not establish a minimum effective dose.
Study evidence
Ginkgo Supportive 11 studies
Productivity Boost
Impact
Moderate effect
A Ingredient FitF PathwaysD+ EvidenceA+ Formulation Logic

Ginkgo is linked to memory and attention, but findings are mixed and its relevance to routine productivity is limited. The saved assessment includes separate 60 mg and 200 mg declarations, so the product name alone does not describe the assessed amount.

How this product is rated for Productivity Boost

Ingredient fit94

The assessed active ingredient is closely aligned with the goal, though it is also linked to other uses. The credited ingredients reach the full amounts used in the saved assessment.
Goal fit
The assessed active ingredient is closely aligned with the goal, though it is also linked to other uses.
Dose adequacy
The credited ingredients reach the full amounts used in the saved assessment.

Pathways13

The strongest saved contribution relates to synaptic plasticity and neuroprotection, with limited coverage. No selected pathway reaches the saved threshold for substantial coverage.
Depth
The strongest saved contribution relates to synaptic plasticity and neuroprotection, with limited coverage.
Breadth
No selected pathway reaches the saved threshold for substantial coverage.

Evidence53

Ginkgo provides the strongest evidence among the ingredients at an assessed effective amount, with limited applicability to actual work output. The saved findings recognize the assessed effective ingredients as studied preparations.
Evidence strength
Ginkgo provides the strongest evidence among the ingredients at an assessed effective amount, with limited applicability to actual work output.
Studied preparation
The saved findings recognize the assessed effective ingredients as studied preparations.

Formulation logic100

The credited ingredients can contribute independently or have their required partners. No configured ingredient conflicts were recorded in the saved findings. All credited ingredients meet the saved minimum for a meaningful amount.
Partner coverage
The credited ingredients can contribute independently or have their required partners.
Conflicts
No configured ingredient conflicts were recorded in the saved findings.
Effective doses
All credited ingredients meet the saved minimum for a meaningful amount.
Study evidence
Ginkgo Supportive 20 studies
Mental Focus
Impact
Moderate effect
A Ingredient FitD- PathwaysC EvidenceA+ Formulation Logic

Ginkgo is the ingredient relevant to cognitive support, with separate 60 mg and 200 mg declarations retained in the supplied assessment. Attention findings remain mixed, and a larger declared total does not by itself imply a stronger concentration benefit.

How this product is rated for Mental Focus

Ingredient fit94

The assessed ingredients are closely centered on cognitive support, although the formula is also linked to other goals. The amounts of the ingredients included in the saved assessment fully meet its dose benchmarks.
Goal fit
The assessed ingredients are closely centered on cognitive support, although the formula is also linked to other goals.
Dose adequacy
The amounts of the ingredients included in the saved assessment fully meet its dose benchmarks.

Pathways44

Support associated with cerebral energy supply is the strongest mechanism in the saved findings. One of the three target mechanisms reaches the saved coverage threshold, so coverage remains concentrated in one area.
Depth
Support associated with cerebral energy supply is the strongest mechanism in the saved findings.
Breadth
One of the three target mechanisms reaches the saved coverage threshold, so coverage remains concentrated in one area.

Evidence62

Ginkgo provides the strongest saved evidence rating here, although attention findings are mixed. The saved assessment recognizes the preparations of all ingredients included at qualifying amounts.
Evidence strength
Ginkgo provides the strongest saved evidence rating here, although attention findings are mixed.
Studied preparation
The saved assessment recognizes the preparations of all ingredients included at qualifying amounts.

Formulation logic100

The saved findings identify no missing required partner for the included ingredients. No configured ingredient conflict was found in the saved assessment. All ingredients included in this finding reach the saved minimum dose threshold.
Partner coverage
The saved findings identify no missing required partner for the included ingredients.
Conflicts
No configured ingredient conflict was found in the saved assessment.
Effective doses
All ingredients included in this finding reach the saved minimum dose threshold.
Study evidence
Ginkgo Supportive 28 studies

Ingredients

IngredientAmount per servingScore
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones)
60 mg 55
Ginkgo powder
200 mg 55
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Women Vegetarian
Report overview
F Composition And Label DisclosureA+ Composition And Label Disclosure
A serving lists 60 mg of ginkgo leaf extract and 200 mg of ginkgo powder. The extract is listed as 6% terpenes; no marker percentages are recorded for the powder.
How this ingredient is rated

Composition and Label Disclosure10

The extract is listed as 6% terpenes; no flavone percentage is recorded for it, and no marker percentages are recorded for the powder. No ginkgolic acid limit is recorded in the saved facts.
Marker and Preparation Disclosure
The extract is listed as 6% terpenes; no flavone percentage is recorded for it, and no marker percentages are recorded for the powder.
Declared Ginkgolic Acid Limit
No ginkgolic acid limit is recorded in the saved facts.

Composition and Label Disclosure100

A serving separately lists 60 mg of ginkgo leaf extract and 200 mg of ginkgo powder.
Individual Preparation Amount Disclosure
A serving separately lists 60 mg of ginkgo leaf extract and 200 mg of ginkgo powder.

Commercial Price and Usability

No price comparison was evaluated.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  4. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  5. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  6. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  7. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support forGinkgo
  8. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  9. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  10. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsEye Health forGinkgo
  11. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsEye Health forGinkgo
  12. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsEye Health forGinkgo
  13. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsEye Health forGinkgo
  14. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsEye Health forGinkgo
  15. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  16. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  17. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  18. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  19. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  20. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo